Stay updated with breaking news from 0fgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research note released on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. FibroGen Stock Performance Shares of NASDAQ:FGEN opened at $0.62 on Friday. FibroGen has a 12-month low of $0.33 and a 12-month high of $25.69. The […]
StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research note released on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, Bank of America cut shares of FibroGen from a neutral rating to an underperform rating and cut their price objective for the stock from […]
FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) saw a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 11,450,000 shares, a growth of 8.9% from the September 30th total of 10,510,000 shares. Based on an average daily trading volume, of 4,370,000 shares, the days-to-cover ratio […]
Logos Global Management LP cut its holdings in FibroGen, Inc. (NASDAQ:FGEN – Free Report) by 42.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 300,000 shares of the biopharmaceutical company’s stock after selling 225,000 shares during the […]
Shares of FibroGen Inc. fell 23% premarket on Wednesday after the company said its investigational treatment for Duchenne muscular dystrophy failed to meet...